Cullinan Therapeutics, Inc. CGEM Invested capital
Discontinued — last reported Q4 '25
Invested capital at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s invested capital?
- Cullinan Therapeutics, Inc. (CGEM) reported invested capital of $323.08M in Q4 2025.
- How has Cullinan Therapeutics, Inc.'s invested capital changed year-over-year?
- Cullinan Therapeutics, Inc.'s invested capital decreased by 36.6% year-over-year, from $509.47M to $323.08M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s invested capital has grown at a -3.1% compound annual growth rate (CAGR), from $366.57M to $323.08M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).